Endogenous mediators of resolution

B. Levy (Boston, United States of America)

Source: Annual Congress 2006 - Resolution of airway and tissue inflammation “ emerging concepts
Session: Resolution of airway and tissue inflammation “ emerging concepts
Session type: Symposium
Number: 3043
Disease area: Airway diseases

Slide presentationMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
B. Levy (Boston, United States of America). Endogenous mediators of resolution. Annual Congress 2006 - Resolution of airway and tissue inflammation “ emerging concepts

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
An update on anti-inflammatory endogenous mediators
Source: Annual Congress 2005 - Mechanisms of resolution of inflammation
Year: 2005

Inflammatory response to infectious pulmonary injury
Source: Eur Respir J 2003; 22: 10S-14S
Year: 2003



Stimulation of acetylcholine receptors impairs host defence during pneumococcal pneumonia
Source: Eur Respir J 2009; 33: 375-381
Year: 2009



Endogenous lipid mediators in the resolution of airway inflammation
Source: Eur Respir J 2007; 30: 980-992
Year: 2007



Resolution of inflammation in airway diseases
Source: Annual Congress 2005 - Mechanisms of resolution of inflammation
Year: 2005

Chronic inflammation in asthma
Source: ISSN=1025-448x, ISBN=1-904097-26-x, page=126
Year: 2003

Differential gene expression and cytokine production from neutrophils in asthma phenotypes
Source: Eur Respir J 2010; 35: 522-531
Year: 2010



The antimicrobial peptide CRAMP is a regulator of inflammation during pneumonia
Source: Annual Congress 2006 - Immunology of the airways
Year: 2006


Hsp90 binding inhibitors improve survival in a murine model of sepsis induced acute lung injury
Source: Annual Congress 2006 - Novel pathogenic aspects of acute lung injury and acute respiratory distress syndrome (ARDS)
Year: 2006


A role of GM-CSF in the accumulation of neutrophils in the airways caused by IL-17 and TNF-α
Source: Eur Respir J 2003; 21: 387-393
Year: 2003



Streptococcus pneumoniae-induced regulation of cyclooxygenase-2 in human lung tissue
Source: Eur Respir J 2012; 40: 1458-1467
Year: 2012



Rhinovirus induces airway fibroblast release of neutrophil but not eosinophil chemokines
Source: Annual Congress 2005 - Host-pathogen interaction in respiratory virus infections
Year: 2005


Development of new treatments for complex chronic comorbidities
Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases
Year: 2006



The balance of pro- and anti - inflammatory cytokines in Chlamydia pneumoniae infected cells as a marker of inflammatory activity in the pulmonary compartment
Source: Eur Respir J 2001; 18: Suppl. 33, 154s
Year: 2001

Chemokines, innate and adaptive immunity, and respiratory disease
Source: Eur Respir J 2002; 19: 350-355
Year: 2002



Treatment: how does inflammatory phenotype influence response to treatment in airway disease?
Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease
Year: 2007


Adhesion molecules LFA-1(CD11a), Mac-1(CD11b), ICAM-1l(CD54) of T-lymphocytes, IL-1β, IL-1ra and IL-4 in serum of patients with inflammatory diseases of the lower respiratory tract
Source: Eur Respir J 2003; 22: Suppl. 45, 85s
Year: 2003

Free, soluble interleukin-17 protein during severe inflammation in human airways
Source: Eur Respir J 2002; 19: 534-537
Year: 2002



Interferon-β augments eosinophil adhesion-inducing activity of endothelial cells
Source: Eur Respir J 2008; 32: 1540-1547
Year: 2008



Upregulated response to chemokines in oxidative metabolism of eosinophils in asthma and allergic rhinitis
Source: Eur Respir J 2003; 21: 925-931
Year: 2003